DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence
En podcast av DrugPatentWatch
100 Avsnitt
-
Introducing DrugChatter: Revolutionizing Information Access
Publicerades: 2024-06-25 -
USPTO Study Reveals Trends and Insights into Drug Patent and Exclusivity Trends in the Pharmaceutical Industry
Publicerades: 2024-06-25 -
Leveraging 505(b)(2) to Innovate Beyond Existing Drug Patents
Publicerades: 2024-06-24 -
The Intricate Journey of Drug Patents: From Filing to Expiry
Publicerades: 2024-06-20 -
Uncovering Lucrative Low-Competition Generic Drug Opportunities
Publicerades: 2024-06-19 -
Maximizing ROI with Branded Generics: A Comprehensive Guide
Publicerades: 2024-06-18 -
A Practical Guide to FtO Analysis for Drug Repurposing Ventures
Publicerades: 2024-06-17 -
Divisional Patent Minefields: Navigating Big Pharma’s Patent Extension Strategies
Publicerades: 2024-06-17 -
Innovative Approaches to Extend the Life of Drug Patents
Publicerades: 2024-06-17 -
How long does a patent last for drugs?
Publicerades: 2024-06-12 -
Crucial Insights on Patent Litigation Strategies in Pharma Industry
Publicerades: 2024-06-10 -
Underutilized Opportunities: Exploring Patent Term Extensions for Medical Devices
Publicerades: 2024-06-06 -
Innovative Strategies in Drug Repurposing
Publicerades: 2024-04-23 -
AI-Driven Drug Discovery: Transforming the Landscape of Pharmaceutical Research
Publicerades: 2024-04-16 -
Innovative Financing Models for Repurposing Generic Drugs
Publicerades: 2024-04-11 -
Biosimilar Competition Does Not Reduce Patient Out-of-Pocket Costs for Biologic Drugs
Publicerades: 2024-03-31 -
Unleashing Innovation: The Case for Permissionless R&D in Pharma
Publicerades: 2024-03-22 -
LACTOSE-Free Medicines: Which Drugs Contain LACTOSE?
Publicerades: 2024-03-08 -
GELATIN-Free Medicines: Which Drugs Contain GELATIN?
Publicerades: 2024-03-06 -
Cost-Cut Without Compromise: Navigating Excipient Switching in Pharma
Publicerades: 2024-02-26
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
